|Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease|
K Cusi, Z Chang, S Harrison, R Lomonaco, F Bril, B Orsak, C Ortiz-Lopez, ...
Journal of hepatology 60 (1), 167-174, 2014
|Lineage of origin in rhabdomyosarcoma informs pharmacological response|
J Abraham, Y Nuñez-Álvarez, S Hettmer, E Carrió, HIH Chen, K Nishijo, ...
Genes & development 28 (14), 1578-1591, 2014
|Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer|
S Patel, V Hurez, ST Nawrocki, M Goros, J Michalek, J Sarantopoulos, ...
Oncotarget 7 (37), 59087, 2016
|Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer|
MA Liss, JR White, M Goros, J Gelfond, R Leach, T Johnson-Pais, Z Lai, ...
European urology 74 (5), 575-582, 2018
|Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar Rhabdomyosarcoma|
MI Aslam, S Hettmer, J Abraham, D LaTocha, A Soundararajan, ...
Molecular Cancer Research 11 (11), 1303-1313, 2013
|Drug overdose: differing risk models for women and men among opioid users with non-cancer pain|
Y Liang, MW Goros, BJ Turner
Pain medicine 17 (12), 2268-2279, 2016
|An evaluation of elderly patients (≥ 70 years old) enrolled in Phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research …|
J Rowe, S Patel, M Mazo-Canola, A Parra, M Goros, J Michalek, K Kelly, ...
Journal of geriatric oncology 5 (1), 65-70, 2014
|Serial percent free prostate specific antigen in combination with prostate specific antigen for population based early detection of prostate cancer|
DP Ankerst, J Gelfond, M Goros, J Herrera, A Strobl, IM Thompson, ...
The Journal of urology 196 (2), 355-360, 2016
|The HDAC3–SMARCA4–miR-27a axis promotes expression of the PAX3: FOXO1 fusion oncogene in rhabdomyosarcoma|
N Bharathy, NE Berlow, E Wang, J Abraham, TP Settelmeyer, JE Hooper, ...
Science signaling 11 (557), 2018
|A system for an accountable data analysis process in R|
J Gelfond, M Goros, B Hernandez, A Bokov
The R journal 10 (1), 6, 2018
|The effect of trabeculae carneae on left ventricular diastolic compliance: Improvement in compliance with trabecular cutting|
DL Halaney, A Sanyal, NA Nafissi, D Escobedo, M Goros, J Michalek, ...
Journal of biomechanical engineering 139 (3), 2017
|p53‐Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study|
CS Ha, JE Michalek, R Elledge, KR Kelly, S Ganapathy, H Su, CA Jenkins, ...
Molecular oncology 10 (1), 148-156, 2016
|Assisted hatching and live births in first-cycle frozen embryo transfers|
JF Knudtson, CM Failor, JA Gelfond, MW Goros, TA Chang, RS Schenken, ...
Fertility and sterility 108 (4), 628-634, 2017
|Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trials|
L Malik, H Parsons, D Mahalingam, B Ehler, M Goros, A Mejia, A Brenner, ...
Clinical genitourinary cancer 12 (5), 359-365, 2014
|Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study|
MA Liss, O Al-Bayati, J Gelfond, M Goros, S Ullevig, J DiGiovanni, ...
Prostate cancer and prostatic diseases 22 (2), 244, 2019
|Incorporation of urinary prostate cancer antigen 3 and tmprss2: Erg into prostate cancer prevention trial risk calculator|
DP Ankerst, M Goros, SA Tomlins, D Patil, Z Feng, JT Wei, MG Sanda, ...
European urology focus 5 (1), 54-61, 2019
|Older stroke patients with high stroke scores have delayed door-to-needle times|
LA Birnbaum, JS Rodriguez, CH Topel, R Behrouz, V Misra, S Palacio, ...
Journal of Stroke and Cerebrovascular Diseases 25 (11), 2668-2672, 2016
|A test of the psychometric characteristics of the BIS-Brief among three groups of youth.|
CW Mathias, MS Stanford, Y Liang, M Goros, NE Charles, AH Sheftall, ...
Psychological assessment 30 (7), 847, 2018
|Processing transdermal alcohol concentration (TAC) data to detect low-level drinking|
JD Roache, TE Karns-Wright, M Goros, N Hill-Kapturczak, CW Mathias, ...
Alcohol 81, 101-110, 2019
|Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma|
NE Berlow, R Rikhi, M Geltzeiler, J Abraham, MN Svalina, LE Davis, ...
BMC cancer 19 (1), 1-23, 2019